JG-231, CAS [[1627126-59-3]]

Produktübersicht

• Artikelname: JG-231, CAS [[1627126-59-3]]
• Artikelnummer: TGM-T70353
• Hersteller Artikelnummer: T70353
• Alternativnummer: TGM-T70353-1MG,TGM-T70353-5MG,TGM-T70353-10MG,TGM-T70353-25MG,TGM-T70353-50MG,TGM-T70353-100MG,TGM-T70353-200MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

JG-231 is a JG-98 analog with anticancer activity.JG-231 inhibits the MDA-MB-231 xenograft tumor model of triple-negative breast cancer (TNBC).JG-231 inhibits the interaction of Hsp70-BAG3.JG-231 inhibits the MDA-MB-231 xenograft tumor model of triple-negative breast cancer (TNBC). JG-231 inhibits MDA-MB-231 xenograft tumor model of triple negative breast cancer (TNBC).

Produkteigenschaften

• Molekulargewicht: 619.47
• Reinheit: 99.79%
• CAS Nummer: [1627126-59-3]
• Formel: C22H18BrCl2N3OS4
• Target-Kategorie: Apoptosis|||HSP

Bilder

T70353